SeaStar Medical (NASDAQ:ICU – Get Free Report) and CochLear (OTCMKTS:CHEOY – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, risk, profitability, earnings and institutional ownership.
Insider & Institutional Ownership
1.7% of SeaStar Medical shares are owned by institutional investors. 0.7% of SeaStar Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Profitability
This table compares SeaStar Medical and CochLear’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| SeaStar Medical | -828.62% | -146.29% | -96.48% |
| CochLear | N/A | N/A | N/A |
Analyst Recommendations
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| SeaStar Medical | 1 | 0 | 1 | 0 | 2.00 |
| CochLear | 0 | 3 | 1 | 1 | 2.60 |
SeaStar Medical presently has a consensus target price of $8.00, suggesting a potential upside of 156.41%. Given SeaStar Medical’s higher probable upside, equities research analysts clearly believe SeaStar Medical is more favorable than CochLear.
Risk and Volatility
SeaStar Medical has a beta of -1.05, meaning that its stock price is 205% less volatile than the S&P 500. Comparatively, CochLear has a beta of 0.74, meaning that its stock price is 26% less volatile than the S&P 500.
Valuation and Earnings
This table compares SeaStar Medical and CochLear”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| SeaStar Medical | $1.44 million | 8.68 | -$12.15 million | ($4.80) | -0.65 |
| CochLear | $1.53 billion | 3.50 | $251.85 million | N/A | N/A |
CochLear has higher revenue and earnings than SeaStar Medical.
Summary
CochLear beats SeaStar Medical on 8 of the 12 factors compared between the two stocks.
About SeaStar Medical
SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.
About CochLear
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Receive News & Ratings for SeaStar Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaStar Medical and related companies with MarketBeat.com's FREE daily email newsletter.
